COVID-19-associated encephalitis or Creutzfeldt-Jakob disease: a case report.
Gooya TayyebiSeyed Kazem MalakoutiBehnam ShariatiLeila KamalzadehPublished in: Neurodegenerative disease management (2021)
Background: Accurate diagnosis and management of patients with rapidly progressive dementia may be challenging during the COVID-19 pandemic, which has negatively influenced the diagnostic performances, medical resource allocation and routine care for all non-COVID-19 diseases. Case Presentation: We herein present a case of a 57-year-old male with rapidly progressive cognitive decline, headache, diplopia, myalgia, unsteady gait, aggression, depression, insomnia, hallucinations and delusions of persecution. COVID-19-associated encephalitis was briefly considered as a differential diagnosis. However, this hypothesis was rejected upon further investigation. A final diagnosis of sporadic Creutzfeldt-Jakob disease was made. Conclusion: A timely and accurate diagnosis of Creutzfeldt-Jakob disease gives patients and their families the chance to receive a good standard of healthcare and avoid extensive evaluations for other conditions.
Keyphrases
- healthcare
- coronavirus disease
- cognitive decline
- sars cov
- mild cognitive impairment
- multiple sclerosis
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- high resolution
- palliative care
- depressive symptoms
- sleep quality
- late onset
- prognostic factors
- cognitive impairment
- pain management
- mass spectrometry
- respiratory syndrome coronavirus
- physical activity
- social media
- affordable care act
- health insurance
- chronic pain